Illinois' Stop-Sale System Achieves Significant Quarterly Results In Battle Against Meth

Electronic Technology Blocks Illegal Sales, Allows Legal Ones

News provided by

National Association of Drug Diversion Investigators

Apr 17, 2012, 09:00 ET

LUTHERVILLE, Md., April 17, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest quarterly results achieved by the real-time, stop-sale system in Illinois. Data released by the National Precursor Log Exchange (NPLEx) shows electronic technology in the Prairie State during the first quarter of 2012 blocked the sale of more than 15,000 boxes of medicines containing pseudoephedrine (PSE) preventing more than 34,000 grams from potentially being diverted by meth criminals.

"Illinois' real-time, stop-sale technology is working extremely well. Law enforcement officials around the state have used NPLEx data to make arrests and retailers have blocked thousands of unlawful sales," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "In addition to empowering law enforcement officials and retailers, NPLEx also protects law-abiding consumers' access to the cold and allergy medicines they depend on for relief. Other states that don't have NPLEx should look to Illinois as a model of the system's undeniable potential."

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.

SOURCE National Association of Drug Diversion Investigators